Brian Rini, MD, FASCO

Thomas Powles, MBBS, MRCP, MD

Laurence Albiges, MD, PhD

David F. McDermott, MD

Hans Hammers, MD, PhD

AZGUONC-PRODUCTIONwarmup

At Uromigos Live 2024, a panel moderated by Brian Rini focused on the use of front-line therapy in papillary renal cancer and featured discussion on new and upcoming data in the field. The panel featured Tom Powles along with guests Laurence Albiges, MD, Institute Gustave-Roussy; David McDermott, MD, Beth Israel Deaconess Medical Center; and Hans Hammers, MD, UT Southwestern Medical Center. 
In part one of the session, the panelists dive into an in-depth exploration and debate on the results of the SUNNIFORECAST study in nccRCC.

Uromigos Live 2024 Front-Line Therapy in Papillary RCC Part 1: SUNNIFORECAST Discussion

Renal Cell Carcinoma

In part one of the session, the panelists dive into an in-depth exploration and debate on the results of the SUNNIFORECAST study in nccRCC.

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe